Journal article icon

Journal article

Residues on both faces of the first immunoglobulin fold contribute to homophilic binding sites of PECAM-1/CD31.

Abstract:
CD31 (PECAM-1) is a member of the immunoglobulin superfamily whose extracellular domain is comprised of six immunoglobulin-like domains. It is widely expressed on endothelium, platelets, around 50% of lymphocytes, and cells of myeloid lineage. CD31 has been shown to be involved in interendothelial adhesion and leukocyte-endothelial interactions, particularly during transmigration. CD31-mediated adhesion is complex, because CD31 is capable of mediating both homophilic and multiple heterophilic adhesive interactions. Here we show that the NH2-terminal (membrane-distal) immunoglobulin domain of CD31 is necessary but not sufficient to support stable homophilic adhesion. Key residues forming the binding site within this domain have been identified by analysis of 26 single point mutations, representing the most systematic analysis of a fully homophilic interaction between immunoglobulin superfamily family members to date. This revealed five mutations that affect homophilic binding. Uniquely, the residues involved are exposed on both faces of the immunoglobulin fold, leading us to propose a novel mechanism for CD31 homophilic adhesion.
Publication status:
Published

Actions


Access Document


Publisher copy:
10.1074/jbc.272.33.20555

Authors


More by this author
Institution:
University of Oxford
Division:
MSD
Department:
NDM
Sub department:
Structural Biology
Role:
Author


Journal:
Journal of biological chemistry More from this journal
Volume:
272
Issue:
33
Pages:
20555-20563
Publication date:
1997-08-01
DOI:
EISSN:
1083-351X
ISSN:
0021-9258


Language:
English
Keywords:
Pubs id:
pubs:15642
UUID:
uuid:cd1eeb6e-1988-4cdc-9bb8-c5abf0b0b16a
Local pid:
pubs:15642
Source identifiers:
15642
Deposit date:
2012-12-19

Terms of use



Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP